Tumori Journal · 2012 · 12 citations · 17 references
MedicineMolecular BiologyOncologyGene ExpressionMolecular OncologyOncogenesCancer Cell SignalingColorectal CancerMalignant NeoplasmsOncogenic Signaling PathwaysRna InterferenceSignal Transduction In CancerColorectal Cancer PathologyColorectal Cancer PrognosisColorectal Carcinogenesis PathophysiologyDistant Nodal MetastasisLymphovascular Invasion PrognosisRon Receptor SignalingTumor Size PrognosisTumor Stage Prognosis
Aims and background The aims of the current study were to evaluate whether recepteur d'origine nantais (RON) affects tumor cell behavior and oncogenic signaling pathways in colorectal cancer, and to examine the relationship of its expression with various clinicopathological parameters and patient survival. Methods Immunohistochemistry, Western blot and RT-PCR were used to detect the expression of the RON gene in human colorectal cancer tissue. To study the biological role of RON in tumor cell behavior and cellular signaling pathways, we used small interfering RNA (siRNA) to knock down RON gene expression in human colorectal cancer cell lines. Results Knockdown of RON inhibited the induction of the invasive growth phenotype and the activation of oncogenic signaling pathways including Akt, MAPK and β-catenin. RON overexpression was associated with tumor size, lymphovascular invasion, depth of invasion, lymph node metastasis, distant metastasis, tumor stage and poor survival. Conclusions These results suggest that RON overexpression may help in predicting poor clinical outcomes in colorectal cancer.
17
Akt Phosphorylation of BAD Couples Survival Signals to the Cell-Intrinsic Death Machinery
Sandeep Robert Datta, Henryk Dudek, Xu Tao et al. · Cell · 1997 · 5.7K citations · Full text
Overexpression of the RON gene in human breast carcinoma
Piera Maggiora, Serena Marchiò, Maria Cristina Stella et al. · Oncogene · 1998 · 220 citations
Ryan M. Thomas, Kenya Toney, Cecilia M. Fenoglio‐Preiser et al. · Cancer Research · 2007 · 147 citations · Full text
Medicine, Cancer Biology, Oncology +17